Novo Eclipses $500 Billion Market Value on Wegovy Frenzy

preview_player
Показать описание
Novo Nordisk CEO Lars Fruergaard Jorgensen discusses plans to launch the weight-loss drug Wegovy in Europe this year, expanding capex to boost production, and the company achieving a $500 billion market value.

--------
Connect with us on...
Рекомендации по теме